Catalyst Pharmaceuticals (CPRX) – Analyst EPS Change
-
Catalyst Pharmaceutical Partners (CPRX) PT Raised to $9 at Oppenheimer Following 'Pre-Launch' Call
-
UPDATE: Catalyst Pharmaceutical Partners (CPRX) PT Raised to $6 at Roth Capital Following 4Q
Back to CPRX Stock Lookup